 Connection
David Moreno to Recurrence
This is a "connection" page, showing publications David Moreno has written about Recurrence.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.090 |
|
|
|
-
Torrecillas-Mayayo V, Oliver-Caldes A, Martínez-Cibrian N, Albiol N, Rodríguez-Lobato LG, Español-Rego M, Ortiz-Maldonado V, Rosiñol L, Tovar N, Navarro-Velasquez S, Charry P, Munárriz D, Mateos JM, Jimenez-Mira C, Moreno DF, Montoro M, Ayora P, Delgado J, Juan M, González-Navarro A, Cibeira MT, Fernández de Larrea C. Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT. Ann Hematol. 2026 May 12; 105(7).
Score: 0.047
-
Zugasti I, Tormo-Ratera M, Oliver-Caldés A, Soler-Perromat JC, González-Calle V, Moreno DF, Cabañas V, López-Muñoz N, Bartolomé-Solanas Á, Español-Rego M, Reguera-Ortega JL, Rosiñol L, López-Corral L, Tovar N, Rodríguez-Lobato LG, Alvarez Perez RM, Varea S, Olesti E, Gomez-Grande A, Frutos L, Tamayo P, Juan M, Moraleda JM, Urbano-Ispizua Á, González-Navarro EA, Martínez-López J, Mateos MV, Tomás X, Setoain X, Fernández de Larrea C. Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma. Blood Adv. 2025 Feb 11; 9(3):571-582.
Score: 0.043
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|